PD-0299685

Pharmaceutical compound From Wikipedia, the free encyclopedia

PD-0299685 is a gabapentinoid (α2δ subunit-containing voltage-gated calcium channel blocker) which was under development for the treatment of insomnia and vasomotor symptoms (hot flashes) related to menopause as well as interstitial cystitis.[1][2][3] It is taken orally.[1] PD-0299685 was under development by Pfizer.[1] It reached phase 2 clinical trials prior to the discontinuation of its development.[1]

Other namesPD-0299685; PD-299685; PD0299685; PD299685; PD-299,685
ATC code
  • None
Quick facts Clinical data, Other names ...
PD-0299685
Clinical data
Other namesPD-0299685; PD-299685; PD0299685; PD299685; PD-299,685
Routes of
administration
Oral[1]
Drug classGabapentinoid
ATC code
  • None
Identifiers
  • (3S,5R)-3-(aminomethyl)-5-methyloctanoic acid
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
ChEMBL
Chemical and physical data
FormulaC10H21NO2
Molar mass187.283 g·mol−1
3D model (JSmol)
  • CCC[C@@H](C)C[C@@H](CC(=O)O)CN
  • InChI=1S/C10H21NO2/c1-3-4-8(2)5-9(7-11)6-10(12)13/h8-9H,3-7,11H2,1-2H3,(H,12,13)/t8-,9+/m1/s1
  • Key:KKXFMWXZXDUYBF-BDAKNGLRSA-N
Close

See also

References

Related Articles

Wikiwand AI